SUPERA S-65-100-120-P6 (UDI 08717648226281)Recalls & reported problems
Abbott Vascular Inc. · Supera Peripheral Stent System 6.5 mm x 100 mm x 120 cm 6 F · Class 3 · Implant
All models of SUPERA (55)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08717648226281), received between May 25, 2018 and Jun 3, 2022 — classified as 1 injury, 3 malfunctions.
The most frequently reported specific device problem is “Activation Failure” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Activation Failure2
- Improper or Incorrect Procedure or Method2
- Adverse Event Without Identified Device or Use Problem1
- Difficult to Remove1
- Entrapment of Device1
- Material Separation1
- Stretched1
Patient problems
- No Consequences Or Impact To Patient2
- No Clinical Signs, Symptoms or Conditions1
- Vessel Or Plaque, Device Embedded In1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 3, 2022Improper or Incorrect Procedure or Method; Activation Failure; Improper or Incorrect Procedure or Method; Activation Failure
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION LOCATED IN THE SUPERFICIAL FEMORAL ARTERY (SFA) THAT WAS MILDLY CALCIFIED. THE SUPERA STENT SYSTEM WAS ADVANCED TO THE TARGET LESION WITHOUT RESISTANCE AND THE STENT WAS DEPLOYED; HOWEVER, WHILE REMOVING THE DELIVERY SYSTEM, THE STENT WAS REMOVED AS WELL. IT WAS SUSPECTED THAT FLUOROSCOPY WAS NOT USED WHEN REMOVING THE DELIVERY SYSTEM. THERE WAS NO ADVERSE PATIENT EFFECT AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. THE PROCEDURE WAS ABORTED AS THE ACCESS SITE HAD BEEN LOST. THE PATIENT WILL BE MONITORED UNTIL ANOTHER PROCEDURE IS PERFORMED. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14597380 ↗InjuryNov 13, 2019Entrapment of Device; Material Separation; Entrapment of Device; Material Separation
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A SUPERFICIAL FEMORAL ARTERY (SFA). AFTER INTRODUCING A 6.5X100MM SUPERA SELF-EXPANDING STENT DELIVERY SYSTEM INTO THE ANATOMY, THE TIP OF THE STENT BROKE OFF WHILE ATTEMPTING TO DEPLOY. THE NOSE CONE GOT CAUGHT AT THE END OF THE STENT, HOWEVER THE STENT WAS ABLE TO BE DEPLOYED SUCCESSFULLY. THE PHYSICIAN DID NOT HAVE A SNARE DEVICE TO REMOVE THE TIP, SO A SECOND STENT WAS DEPLOYED OVER THE TIP WITH A GOOD RESULT. THE TIP STILL REMAINS IN THE ANATOMY. THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE AND NO ADVERSE PATIENT EFFECTS. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Vessel Or Plaque, Device Embedded In
MAUDE report 9315282 ↗MalfunctionMar 14, 2019Difficult to Remove; Stretched; Activation Failure; Difficult to Remove; Stretched; Activation Failure
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A SUPERFICIAL FEMORAL ARTERY. AN UNSPECIFIED SUPERA STENT WAS DEPLOYED WITHOUT ISSUE AT THE LESION. THEN A SECOND 6.5X100MM SUPERA STENT WAS PLANNED FOR IMPLANT. THE PHYSICIAN PUSHED THE THUMBWHEEL FULLY FORWARD AND HAD ASSUMED THAT THE SUPERA STENT HAD DEPLOYED FULLY AT THE LESION. HOWEVER, THE STENT ONLY PARTIALLY DEPLOYED, STILL PART OF IT INSIDE THE CATHETER. THE PHYSICIAN THEN PULLED THE CATHETER FOR REMOVAL WHEN RESISTANCE WAS NOTED WITH THE INTRODUCER SHEATH. THE PHYSICIAN THEN REALIZED THE SUPERA STENT HAD ONLY BEEN PARTIALLY DEPLOYED. THE SHEATH WITH THE STENT WAS REMOVED ALTOGETHER AS A SINGLE UNIT. ONCE OUTSIDE OF THE ANATOMY, IT WAS NOTED THAT THE SUPERA STENT HAD STRETCHED. A NEW SHEATH AND NON-ABBOTT STENT WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8422583 ↗MalfunctionMay 25, 2018Improper or Incorrect Procedure or Method; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT ON (B)(6) 2018 THE SUPERA STENT WAS SUCCESSFULLY IMPLANTED IN THE SUPERFICIAL FEMORAL ARTERY. IT WAS NOTED ON (B)(6) 2018 THAT THE IMPLANTED STENT HAD EXPIRED ON (B)(6) 2018. THERE WERE NO ADVERSE PATIENT EFFECTS FROM USE OF THE EXPIRED DEVICE. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7546536 ↗
Other STENT, SUPERFICIAL FEMORAL ARTERY devices
- EverFlex™ EVD35-06-150-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 death110 reports
- SUPERA S-60-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY108 reports
- SUPERA S-55-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY88 reports
- LifeStent® Solo Vascular Stent EX062003CLBard Peripheral Vascular, Inc. · STENT, SUPERFICIAL FEMORAL ARTERY80 reports
- BioMimics 3D Vascular Stent System 144700-12Veryan Medical Limited · Stent, Superficial Femoral Artery74 reports
- SUPERA S-50-120-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY55 reports
- EverFlex™ EVD35-07-060-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
- EverFlex™ EVD35-07-120-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page